Ae Hee Kim
Yonsei University · Medicine
About the Lab
Professor Ae Hee Kim's research lab specializes in metabolic and cardiovascular disease epidemiology, with a focus on identifying novel, clinically applicable biomarkers and risk prediction models for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic syndrome (MetS). The lab investigates the role of metabolic and antioxidant markers—such as triglyceride-glucose index (TyG) and bilirubin—in predicting and stratifying metabolic disease risk, particularly through large-scale, population-based cohort studies. Their work emphasizes translational research that bridges clinical practice and public health by developing simple, feasible tools for early detection and prevention.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
5Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is newly proposed nomenclature, and its diagnosis involves an algorithm that can be complicated and impractical for clinicians in real-world clinical settings. Thus, we investigated the association between MAFLD and modified triglyceride-glucose index (TyG) indices to find a more concise, feasible method for predicting MAFLD in everyday clinical care. Methods: Data were obtained from people who voluntarily underwent healt
BACKGROUND: Research on identifiable risks for metabolic syndrome (MetS) is ongoing, and growing evidence suggests that bilirubin is a potent antioxidant and cytoprotective agent against MetS. However, there have been conflicting results on the association between bilirubin and MetS. Our study aimed to validate the association by separately stratifying data for men and women in a longitudinal prospective study. METHODS: Data were derived from the Korean Genome Epidemiology Study provided by the
Research Areas
Dive deeper into Ae Hee Kim's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.